EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Development of an IgG4-RD Responder Index

Mollie N Carruthers, John H Stone, Vikram Deshpande, Arezou Khosroshahi

International Journal of Rheumatology · 2012 · 2012 · 1-7

DOI: 10.1155/2012/259408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatology, 2012. Verfasst von Mollie N Carruthers und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. Die Arbeit wurde bisher 208-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgG4-related disease (IgG4-RD) is a multiorgan inflammatory disease in which diverse organ manifestations are linked by common histopathological and immunohistochemical features. Prospective studies of IgG4-RD patients are required to clarify the natural history, long-term prognosis, and treatment approaches in this recently recognized condition. Patients with IgG4-RD have different organ manifestations and are followed by multiple specialties. Divergent approaches to the assessment of patients can complicate the interpretation of studies, emphasizing the critical need for validated outcome measures, particularly assessments of disease activity and response to treatment. We developed a prototype IgG4-RD Responder Index (IgG4-RD RI) based on the approach used in the development of the Birmingham Vasculitis Activity Score for Wegener’s granulomatosis (BVAS/WG). The IgG4-RD RI was refined by members of the International IgG4-RD Symposium Organizing Committee in a paper case exercise. The revised instrument was applied retrospectively to fifteen IgG4-RD patients at our institution. Those scores were compared to physician’s global assessment scale for the same visits. This paper describes the philosophy and goals of the IgG4-RD RI, the steps in the development of this instrument to date, and future plans for validation of this instrument as an outcome measure.

Autor:innen und Institutionen

  • Rheumatology Unit, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

Zitieren

APA

Carruthers, M. N., Stone, J. H., Deshpande, V., & Khosroshahi, A. (2012). Development of an IgG4-RD Responder Index. International Journal of Rheumatology, 2012, 1-7. https://doi.org/10.1155/2012/259408

Vancouver

Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. International Journal of Rheumatology. 2012;2012:1-7. doi:10.1155/2012/259408

BibTeX
@article{Carruthers2012,
  author = {Carruthers, Mollie N and Stone, John H and Deshpande, Vikram and Khosroshahi, Arezou},
  title = {Development of an IgG4-RD Responder Index},
  journal = {International Journal of Rheumatology},
  year = {2012},
  volume = {2012},
  pages = {1--7},
  doi = {10.1155/2012/259408}
}
Kostenlos starten →